Biotech Advancements 1. Novartis Acquires Avidity Biosciences for USD 12 Billion Overview: On 26 October 2025 , Novartis AG announced its acquisition of Avidity Biosciences  in a landmark USD 12 billion  deal, valuing Avidity at approximately USD 72 per share , a 46 % premium  over its market price. Avidity, renowned for its RNA-based therapeutic platforms and late-stage rare-disease pipeline, will now operate under the Novartis umbrella. Significance of the Advancement: This

Latest Worldwide Advances in Disease Care Services, Last Week of October 2025   Introduction The final week of October 2025 presents a global healthcare landscape defined by a stark dichotomy: while unprecedented therapeutic innovations signal a future of curative medicine, acute economic shocks and policy paralysis in major Western markets reveal profound systemic fragility. This report provides a strategic analysis of these divergent forces, examining critical developments

The quarter ending June 2025 represented a pivotal inflection point for five leading consumer technology and fintech companies—Uber, Spotify, Netflix, Robinhood, and Shopify—each demonstrating distinct growth trajectories and strategic positioning within rapidly evolving digital markets. Robinhood led revenue growth at 45% YoY, driven by explosive options (+46%) and crypto (+98%) trading surge Shopify delivered 31% revenue growth with accelerating GMV (+31%) and record FCF ma